Nippon Boehringer Ingelheim and Pfizer Japan jointly announced on October 25 the results of their awareness survey on chronic obstructive pulmonary disease (COPD), in which 7,609 people aged 40 or older (4,364 men and 3,245 women) answered via the Internet from September 16 to 20.
